Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sundström

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Neurofilament light as a prognostic marker in multiple sclerosisJonatan Salzer, Anders Svenningsson, Peter Sundström
Journal of Neurology|January 21, 2021
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosisMalin Boremalm, Peter Sundström, Jonatan Salzer
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2013
The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on ageJonatan Salzer, Hans Stenlund, Peter Sundström
Expert Review of Neurotherapeutics|December 11, 2013
Vitamin D and multiple sclerosis: where do we go from here?Jonatan Salzer, Martin Biström, Peter Sundström
Journal of Neuroimmunology|September 8, 2009
Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosisPeter Sundström, Maria Nyström, Kristina Ruuth, et al.
Neurological Research|September 13, 2014
Lumbar puncture preferences among Swedish neurologistsJonatan Salzer, Peter Sundström, Mattias Vågberg, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Inflammatory activity and vitamin D levels in an MS population treated with rituximabJohan Linden, Gabriel Granåsen, Jonatan Salzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2013
Vitamin A and systemic inflammation as protective factors in multiple sclerosisJonatan Salzer, Göran Hallmans, Maria Nyström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2013
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samplesJonatan Salzer, Maria Nyström, Göran Hallmans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2012
Smoking as a risk factor for multiple sclerosisJonatan Salzer, Göran Hallmans, Maria Nyström, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Neurofilament light as a prognostic marker in multiple sclerosisJonatan Salzer, Anders Svenningsson, Peter Sundström
Journal of Neurology|January 21, 2021
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosisMalin Boremalm, Peter Sundström, Jonatan Salzer
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2013
The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on ageJonatan Salzer, Hans Stenlund, Peter Sundström
Expert Review of Neurotherapeutics|December 11, 2013
Vitamin D and multiple sclerosis: where do we go from here?Jonatan Salzer, Martin Biström, Peter Sundström
Journal of Neuroimmunology|September 8, 2009
Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosisPeter Sundström, Maria Nyström, Kristina Ruuth, et al.
Neurological Research|September 13, 2014
Lumbar puncture preferences among Swedish neurologistsJonatan Salzer, Peter Sundström, Mattias Vågberg, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Inflammatory activity and vitamin D levels in an MS population treated with rituximabJohan Linden, Gabriel Granåsen, Jonatan Salzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2013
Vitamin A and systemic inflammation as protective factors in multiple sclerosisJonatan Salzer, Göran Hallmans, Maria Nyström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2013
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samplesJonatan Salzer, Maria Nyström, Göran Hallmans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2012
Smoking as a risk factor for multiple sclerosisJonatan Salzer, Göran Hallmans, Maria Nyström, et al.
Pageof 6